childhood

childhood

childhood

Reaction to study associating skipping breakfast or eating breakfast away from home with increased risk of psychosocial problems in childhood and adolescence

Using data from the 2017 National Health Interview Survey, researchers show that children and adolescents (aged 4-14 years) who skip breakfast or eat it away from home are more likely to have psychosocial behavioural problems. The research is published in the journal Frontiers in Nutrition.

Reaction to study linking freedom of school choice to racial segregation

Research published in PNAS shows how, in a sample of more than 1,600 racially diverse (black and white) parents in the United States, freedom of school choice, regardless of the presence of students of other ethnicities, also increases segregation. The authors attribute this to different preferences between black parents, who favour higher school ratings, and white parents, who prefer proximity to the school.

Reaction to study associating prenatal exposure to everyday chemicals with childhood liver disease

Analysis of 45 commonly used chemicals in more than 1,000 pregnant women in six countries, including Spain, finds a link between increased exposure to these compounds and non-alcoholic fatty liver disease in children, according to research published in JAMA Network Open. It is the first comprehensive study of prenatal exposure to these chemicals in combination, as they occur in real life.

Reaction to research revealing that infant microbiome development varies according to lifestyle

A metagenomic comparison of the infant gut microbiome of industrialised and non-industrialised populations reveals robust differences that researchers say are lifestyle-dependent. The research involved samples from infants of Hadza, a group of modern hunter-gatherers living in Tanzania, and is published in the journal Science.

Children's covid vaccination in detail: 17 useful questions and answers

The recommendation is to vaccinate children from 5 to 11 years old with the vaccine approved in Europe for this age group, Comirnaty (Pfizer) with one third of the dose used in children over 12 years old. But parents still have doubts. Here we answer the classic ones (safety, risk/benefit) and other more specific ones: allergies, genetic syndromes, high-risk individuals...